TMEM132D-AS1: A Potential Drug Target and Biomarker (G283352)

Target Name: TMEM132D-AS1

NCBI ID: G283352

TMEM132D-AS1

Other Name(s): TMEM132D antisense RNA 1, transcript variant 1 | TMEM132D antisense RNA 1 | TMEM132D-AS1 variant 1

TMEM132D-AS1: A Potential Drug Target and Biomarker

TMEM132D-AS1 is a transcribed RNA molecule that has been identified as a potential drug target and biomarker. It is derived from the TMEM132D gene, which encodes a protein known as tissue-specific murderer (TMEM132D), a protein that is expressed in various tissues throughout the body. TMEM132D-AS1 has been shown to have a unique expression pattern in various tissues, which may be related to its potential drug target status.

TMEM132D-AS1 is a small non-coding RNA molecule that has been shown to play a role in the regulation of gene expression in various tissues. It is expressed in various tissues, including brain, heart, and liver, and has been shown to be involved in the regulation of cell proliferation, apoptosis, and other cellular processes.

One of the key features of TMEM132D-AS1 is its unique expression pattern. Unlike many other RNA molecules, TMEM132D-AS1 is not expressed in all tissues. Instead, it is expressed in specific tissues that are critical for the development and maintenance of tissues. For example, TMEM132D-AS1 is expressed in the brain, which is critical for the development and maintenance of cognitive function. It is also expressed in the heart, which is critical for the development and maintenance of cardiovascular health.

These observations suggest that TMEM132D-AS1 may be a potential drug target, as drugs that are designed to disrupt its expression may have therapeutic benefits. For example, if TMEM132D-AS1 is involved in the regulation of cell apoptosis, drugs that inhibit its expression or activity may be effective in treating cancer or other diseases that are characterized by apoptosis.

In addition to its potential drug target status, TMEM132D-AS1 may also be a biomarker for certain diseases. For example, it may be used as a diagnostic marker for certain types of cancer, such as melanoma or breast cancer. Alternatively, it may be used as a marker for other diseases, such as neurodegenerative disorders or cardiovascular disease.

TMEM132D-AS1 is also worth noting for its unique structure and function. Unlike many other RNA molecules, TMEM132D-AS1 is not a double-stranded RNA molecule. Instead, it is a single-stranded RNA molecule that has a unique 5' end and a unique 3' end. This unique structure may be involved in its function, as it allows it to interact with certain proteins in a specific way.

Further research is needed to fully understand the potential drug target and biomarker status of TMEM132D-AS1. However, its unique expression pattern and structure suggest that it may be a promising target for future research.

Protein Name: TMEM132D Antisense RNA 1

The "TMEM132D-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM132D-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets